Showing results (61-70 of 178) with videos related to
Sort By:
Pageof 18
Trends in Molecular Medicine|June 18, 2024
Senescence and tissue fibrosis: opportunities for therapeutic targetingSteven O'Reilly, Pei-Suen Tsou, John VargaNature Reviews. Rheumatology|September 4, 2021
Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potentialPei-Suen Tsou, John Varga, Steven O'ReillyFrontiers in Immunology|November 1, 2024
Aging, senescence, and cutaneous wound healing-a complex relationshipSteven O'Reilly, Ewa Markiewicz, Olusola C IdowuArthritis Research & Therapy|January 20, 2023
Hyperspectral imaging in systemic sclerosis-associated Raynaud phenomenonShannon Teaw, Akash Gupta, Alyssa Williams, et al.Science Translational Medicine|April 18, 2014
FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signalingSwati Bhattacharyya, Zenshiro Tamaki, Wenxia Wang, et al.Current Rheumatology Reports|January 25, 2017
Innate Immunity in Systemic SclerosisChristopher Dowson, Nathan Simpson, Laura Duffy, et al.Experimental Dermatology|June 28, 2020
Wnt antagonist DKK-1 levels in systemic sclerosis are lower in skin but not in blood and are regulated by microRNA33a-3pJohn Henderson, Stefan Pryzborski, Richard Stratton, et al.Rheumatology (Oxford, England)|May 12, 2012
T cells in systemic sclerosis: a reappraisalSteven O'Reilly, Thomas Hügle, Jacob M van LaarPharmacology & Therapeutics|August 7, 2018
Targeting TLRs and the inflammasome in systemic sclerosisJohn Henderson, Swati Bhattacharyya, John Varga, et al.JCI Insight|July 30, 2020
Regulator combinations identify systemic sclerosis patients with more severe diseaseYue Wang, Jennifer M Franks, Monica Yang, et al.Pageof 18